Influence of Sociodemographic Variables on Patient and Practitioner Knowledge of Pharmacological Management Options for Parkinson's Disease

Introduction: The pharmacological management of Parkinson's Disease (PD) is imperative to improve the quality of life for patients with the disease. However, the extent of knowledge among patients with PD and practitioners of pharmacological management options is unknown. Our primary aim was to investigate patient and practitioner knowledge of pharmacological management options for PD. Our secondary aim was to study the influence of sociodemographic variables on patient and practitioner knowledge of pharmacological management options for PD. Methodology: The Knowledge Attitude Practice (KAP) model was adapted to develop a questionnaire that assesses patient and practitioner knowledge of pharmacological management options for PD. To determine the relationship between sociodemographic variables and patient and practitioner knowledge of pharmacological management options, basic frequency, likelihood-ratio chi-squared, Spearman's correlation, simple logistic regression, and multiple logistic regression analyses were performed. Results: For patients (n = 492) and practitioners (n = 149), the most widely known pharmacological management option was Levodopa-Carbidopa immediate-release tablets, and the least-known was Procyclidine. Compared to patients, practitioners were more likely to have knowledge of most pharmacological management options (OR 1.62 - 9.38). Higher education level (OR 2.56 - 21.01), younger age (OR 0.17 - 0.32), geographical location (Europe OR 1.97 - 9.40, North America OR 0.07 - 0.44, Oceania OR 17.70 - 38.36), ethnicity (4.73 - 5.72), and employment status (OR 0.15 - 0.28) had a significant relationship with patient and practitioner knowledge of pharmacological management options. Conclusion: Practitioners were more likely to have knowledge of most pharmacological management options for PD than patients. Sociodemographic variables such as education level, age, geographical location, ethnicity, and employment status influenced patient and practitioner knowledge of pharmacological management options.

Authors

Institutions

Publication Details

Journal
American Journal of Medical and Clinical Research & Reviews
Published
2025-01-01
DOI
https://doi.org/10.58372/2835-6276.1247
Citations
1
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Influence of Sociodemographic Variables on Patient and Practitioner Knowledge of Pharmacological Management Options for Parkinson's Disease

Mitch Wolden, Paula Abola, Kristin Lefebvre
1 citations
American Journal of Medical and Clinical Research & Reviews
Health Systems, Economic Evaluations, Quality of Life
3.13
article

Influence of Sociodemographic Variables on Patient and Practitioner Knowledge of Pharmacological Management Options for Parkinson's Disease

Mitch Wolden, Paula Abola, Kristin Lefebvre
article en
1 citations

Abstract

Introduction: The pharmacological management of Parkinson's Disease (PD) is imperative to improve the quality of life for patients with the disease. However, the extent of knowledge among patients with PD and practitioners of pharmacological management options is unknown. Our primary aim was to investigate patient and practitioner knowledge of pharmacological management options for PD. Our secondary aim was to study the influence of sociodemographic variables on patient and practitioner knowledge of pharmacological management options for PD. Methodology: The Knowledge Attitude Practice (KAP) model was adapted to develop a questionnaire that assesses patient and practitioner knowledge of pharmacological management options for PD. To determine the relationship between sociodemographic variables and patient and practitioner knowledge of pharmacological management options, basic frequency, likelihood-ratio chi-squared, Spearman's correlation, simple logistic regression, and multiple logistic regression analyses were performed. Results: For patients (n = 492) and practitioners (n = 149), the most widely known pharmacological management option was Levodopa-Carbidopa immediate-release tablets, and the least-known was Procyclidine. Compared to patients, practitioners were more likely to have knowledge of most pharmacological management options (OR 1.62 - 9.38). Higher education level (OR 2.56 - 21.01), younger age (OR 0.17 - 0.32), geographical location (Europe OR 1.97 - 9.40, North America OR 0.07 - 0.44, Oceania OR 17.70 - 38.36), ethnicity (4.73 - 5.72), and employment status (OR 0.15 - 0.28) had a significant relationship with patient and practitioner knowledge of pharmacological management options. Conclusion: Practitioners were more likely to have knowledge of most pharmacological management options for PD than patients. Sociodemographic variables such as education level, age, geographical location, ethnicity, and employment status influenced patient and practitioner knowledge of pharmacological management options.

American Journal of Medical and Clinical Research & ReviewsVol. 04(01)
University of Jamestown (US)
Openalex Percentile: Top 9%
Health Systems, Economic Evaluations, Quality of Life
3.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.